Y. ÜRÜN Et Al. , "Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma," 49th Annual Meeting of the American-Society-of-Hematology , vol.110, Georgia, United States Of America, 2007
ÜRÜN, Y. Et Al. 2007. Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma. 49th Annual Meeting of the American-Society-of-Hematology , (Georgia, United States Of America).
ÜRÜN, Y., Abali, H., Oksuzoglu, B., Budakoglu, B., Yildirim, N., Guler, T., ... Ozet, G.(2007). Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma . 49th Annual Meeting of the American-Society-of-Hematology, Georgia, United States Of America
ÜRÜN, YÜKSEL Et Al. "Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma," 49th Annual Meeting of the American-Society-of-Hematology, Georgia, United States Of America, 2007
ÜRÜN, YÜKSEL Et Al. "Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma." 49th Annual Meeting of the American-Society-of-Hematology , Georgia, United States Of America, 2007
ÜRÜN, Y. Et Al. (2007) . "Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma." 49th Annual Meeting of the American-Society-of-Hematology , Georgia, United States Of America.
@conferencepaper{conferencepaper, author={YÜKSEL ÜRÜN Et Al. }, title={Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma}, congress name={49th Annual Meeting of the American-Society-of-Hematology}, city={Georgia}, country={United States Of America}, year={2007}}